Degron fusion proteins and methods of production and use thereof

Abstract

The present disclosure relates in part to degron-based methods for controlling gene-edited therapeutic cells administered to patients, and targeting constructs encoding degrons, which are suitable for generating gene-edited target cells that can be eliminated following administration to a patient.

Dependencies are inferred from the claim text.